Cantel Medical Corporation
CMD
CMD was delisted on the 1st of June, 2021.
201 hedge funds and large institutions have $2.15B invested in Cantel Medical Corporation in 2015 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 75 increasing their positions, 57 reducing their positions, and 12 closing their positions.
1,133% more call options, than puts
Call options by funds: $2.37M | Put options by funds: $192K
250% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 12
32% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 57
17% more funds holding
Funds holding: 172 → 201 (+29)
10% more capital invested
Capital invested by funds: $1.95B → $2.15B (+$199M)
0% more funds holding in top 10
Funds holding in top 10: 6 → 6 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$12.9M |
| 2 |
Neuberger Berman Group
New York
|
+$11.4M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$6.36M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$4.01M |
| 5 |
Allianz Asset Management
Munich,
Germany
|
+$3.95M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$26.3M |
| 2 |
CCA
Conestoga Capital Advisors
Wayne,
Pennsylvania
|
-$17.8M |
| 3 |
TA
Teton Advisors
Rye,
New York
|
-$15.6M |
| 4 |
SCP
Sandhill Capital Partners
Buffalo,
New York
|
-$5.36M |
| 5 |
CIP
Champlain Investment Partners
Burlington,
Vermont
|
-$5.03M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QI
201
QS Investors
New York
| $1K | +$305 | +5 | New |
|
202
KBC Group
Brussels,
Belgium
| – | -$1.99M | -35,103 | Closed |
|
|
RCM
203
Rotella Capital Management
Bellevue,
Washington
| – | -$912K | -16,091 | Closed |
|
|
TI
204
Trexquant Investment
Stamford,
Connecticut
| – | -$742K | -13,100 | Closed |
|
|
TCT
205
TIAA CREF Trust
St Louis,
Missouri
| – | -$683K | -12,044 | Closed |
|
|
PSC
206
Piper Sandler & Co
Minneapolis,
Minnesota
| – | -$284K | -5,000 | Closed |
|
|
DT
207
Diversified Trust
Memphis,
Tennessee
| – | -$204K | -3,600 | Closed |
|
208
SG Americas Securities
New York
| – | -$114K | -2,006 | Closed |
|
|
KF
209
Krilogy Financial
St. Louis,
Missouri
| – | -$85K | -1,500 | Closed |
|
|
QCG
210
Quadrant Capital Group
Cincinnati,
Ohio
| – | -$77K | -1,359 | Closed |
|
211
Fuller & Thaler Asset Management
San Mateo,
California
| – | -$40K | -700 | Closed |
|
|
W
212
Wealthfront
Palo Alto,
California
| – | -$14K | -253 | Closed |
|
|
SIM
213
Sonora Investment Management
Tucson,
Arizona
| – | -$4K | -81 | Closed |
|
CMD Hedge Fund Activity: Q4 2015 in Review
201 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Cantel Medical Corporation (CMD) for Q4 2015, worth a combined $2.15B — up 10% from $1.95B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new CMD positions and 12 closed out — a net gain of 30 holders — while 75 added to existing stakes and 57 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $12.9M. The largest seller was Brown Capital Management, cutting an estimated $26.3M.
- 201 institutional investors held Cantel Medical Corporation (CMD) as of Q4 2015, up from 172 in Q3 2015.
- Funds reported $2.15B of Cantel Medical Corporation stock for Q4 2015, up 10% quarter-over-quarter.
- 42 funds opened new Cantel Medical Corporation positions in Q4 2015 and 12 closed out, a net change of +30 holders.
- The largest Cantel Medical Corporation buyer in Q4 2015 was T. Rowe Price Associates, an estimated $12.9M added.
- The largest Cantel Medical Corporation seller in Q4 2015 was Brown Capital Management, an estimated $26.3M sold.
Based on aggregated 13F filings for Q4 2015.